Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-30 Purchase | 2023-12-04 4:54 pm | Viracta Therapeutics Inc. | VIRX | Rothera Mark President and CEO | 100,000 | $0.49362 | $49,362 | 100,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-12 Option Award | 2024-03-13 8:36 pm | N/A 2034-03-12 | Viracta Therapeutics Inc. | VIRX | Rothera Mark President and CEO | 475,000 | $0 | 475,000 (Direct) | View |
| 2023-03-16 Option Award | 2023-03-17 5:05 pm | N/A 2033-03-16 | Viracta Therapeutics Inc. | VIRX | Rothera Mark President and CEO | 400,000 | $0 | 400,000 (Direct) | View |
| 2022-09-19 Option Award | 2022-09-19 7:04 pm | N/A 2032-09-19 | Viracta Therapeutics Inc. | VIRX | Rothera Mark President and CEO | 1,375,000 | $0 | 1,375,000 (Direct) | View |
Ownership | 2020-01-02 4:18 pm | N/A N/A | Orchard Therapeutics plc | ORTX | Rothera Mark See Remarks | 0 | $0 | 2,910,469 (Direct) | View |